MMP9 and cancer: After the development of several different mouse monoclonal antibodies against MMP-9 (9, 10), the humanizaton of one mouse monoclonal antibody for clinical trials in cancer was started with the engineering of a chimeric monoclonal antibody (11), followed by safety and phase 2/3 studies in IBD (12).